← 產業報告目錄
GLP-1 Peptide Synthesis CDMO Market Share & Trends Analysis Report, By Synthesis Technology (Solid-Phase Peptide Synthesis (SPPS), Liquid-Phase Peptide Synthesis (LPPS), Group-Assisted Purification Peptide Synthesis (GAP-PS), Hybrid Technology, Recombinant DNA Technology), By Service Type (Analytical and Process Development, Large-Scale Production, Custom Peptide Synthesis, Peptide Modification, Purification Technology, Formulation Development, Regulatory Support, Packaging and Labeling, Pre-Formulation and Registration Batches), By Scale of Operation, By End-User, By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-24頁數 160報告編號 INSIGHTACE-1f5a889802
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the GLP-1 Peptide Synthesis CDMO Market globally will increase at a 12.7% CAGR during 2025–2034.
The GLP-1 Peptide Synthesis CDMO sector involves a member of the incretin hormone family, which plays a crucial role in enhancing insulin secretion in response to gut-derived signals. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is bolstered by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global GLP-1 Peptide Synthesis CDMO Market Snapshot
Chapter 4. Global GLP-1 Peptide Synthesis CDMO Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on GLP-1 Peptide Synthesis CDMO Market Industry Trends
4.10. Global GLP-1 Peptide Synthesis CDMO Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. GLP-1 Peptide Synthesis CDMO Market Segmentation 1: By Synthesis Technology, Estimates & Trend Analysis
5.1. Market Share by Synthesis Technology, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Synthesis Technology:
5.2.1. Solid-Phase Peptide Synthesis (SPPS)
5.2.2. Liquid-Phase Peptide Synthesis (LPPS)
5.2.3. Group-Assisted Purification Peptide Synthesis (GAP-PS)
5.2.4. Hybrid Service Type
5.2.5. Recombinant DNA Service Type
Chapter 6. GLP-1 Peptide Synthesis CDMO Market Segmentation 2: By Service Type, Estimates & Trend Analysis
6.1. Market Share by Service Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type:
6.2.1. Analytical and Process Development
6.2.2. Large-Scale Production
6.2.3. Custom Peptide Synthesis
6.2.4. Peptide Modification
6.2.5. Purification Technology
6.2.6. Formulation Development
6.2.7. Regulatory Support
6.2.8. Packaging and Labeling
6.2.9. Pre-Formulation and Registration Batches
Chapter 7. GLP-1 Peptide Synthesis CDMO Market Segmentation 3: By Scale of Operation, Estimates & Trend Analysis
7.1. Market Share by Scale of Operation, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Scale of Operation:
7.2.1. Clinical-Scale Manufacturing
7.2.2. Commercial-Scale Manufacturing
7.2.3. Pilot-Scale Manufacturing
Chapter 8. GLP-1 Peptide Synthesis CDMO Market Segmentation 4: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
8.2.3. Research Institutions
Chapter 9. GLP-1 Peptide Synthesis CDMO Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global GLP-1 Peptide Synthesis CDMO Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Synthesis Technology, 2021-2034
9.2.3. North America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.2.4. North America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.2.5. North America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Synthesis Technology, 2021-2034
9.3.3. Europe GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.3.4. Europe GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.3.5. Europe GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Synthesis Technology, 2021-2034
9.4.3. Asia Pacific GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.4.4. Asia Pacific GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.4.5. Asia Pacific GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Synthesis Technology, 2021-2034
9.5.3. Latin America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.5.4. Latin America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.5.5. Latin America GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Synthesis Technology, 2021-2034
9.6.3. Middle East & Africa GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.6.4. Middle East & Africa GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by Scale of Operation, 2021-2034
9.6.5. Middle East & Africa GLP-1 Peptide Synthesis CDMO Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Bachem Holding AG
10.2.1.1. Business Overview
10.2.1.2. Key Synthesis Service Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. CordenPharma
10.2.3. PolyPeptide Group
10.2.4. AmbioPharm
10.2.5. CPC Scientific
10.2.6. CSBio
10.2.7. Creative Peptides
10.2.8. Lonza
10.2.9. Aurisco Pharmaceutical
10.2.10. Hybio Pharmaceuticals
10.2.11. Chinese Peptide Company
10.2.12. Neuland Laboratories
10.2.13. Divis Laboratories
10.2.14. Supriya Lifescience
10.2.15. Allsino Pharmaceutical Co. Ltd
10.2.16. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們